Pure Global

Qualitative Test for IgM and IgG Antibodies against HSV-1 - Vietnam Registration 2400179ĐKLH/BYT-HTTB

Access comprehensive regulatory information for Qualitative Test for IgM and IgG Antibodies against HSV-1 in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại C medical device is registered under number 2400179ĐKLH/BYT-HTTB and manufactured by Beijing Genesee Biotech, Inc.. The authorized representative in Vietnam is CÔNG TY TNHH AVANTA DIAGNOSTICS.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
2400179ĐKLH/BYT-HTTB
Registration Details
Vietnam MOH Registration: 2400179ĐKLH/BYT-HTTB
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Qualitative Test for IgM and IgG Antibodies against HSV-1
VN: Khay thử xét nghiệm định tính kháng thể IgM, IgG kháng HSV-1
Risk Class TTBYT Loại C

Registration Details

2400179ĐKLH/BYT-HTTB

000.00.04.G18-220901-0004

OnSite HSV-1 IgG/IgM Rapid Test

R0203C

Company Information

CTK Biotech, Inc.

Technical Details

OnSite HSV-1 IgG/IgM Rapid Test is an immunoassay device, based on the principle of unidirectional flow, for qualitative detection and differentiation of antibodies (IgG and IgM) against herpes simplex virus type 1 (HSV-1) in serum, plasma, or whole blood of humans. It is intended to be used as a screening test by a qualified individual and to provide initial test results, which can support the diagnosis of HSV-1 infection. Any use or interpretation of the results from this preliminary test must be based on clinical manifestations and the professional diagnosis of a physician. Other testing methods must be used to confirm the results obtained from this test kit.

Dates and Status

Feb 04, 2024